BioMarin snags Vertex VP as CMO a month after clinical snafu in gene therapy trial

Press/Media

Period	4 Oct 2021

Media coverage

Title	BioMarin snags Vertex VP as CMO a month after clinical snafu in gene therapy trial
Media name/outlet	FierceBiotech
Country/Territory	United States
Date	4/10/21
URL	https://www.fiercebiotech.com/biotech/biomarin-snags-vertex-vp-as-cmo-a-month-after-clinical-snag-gene-therapy-trial
Persons	Harold Bernstein